首页> 外国专利> PREPARATION OF C1-ESTERASE INHIBITOR (C1-INH), KIT THAT CONSISTS OF A FIRST RECEPTACLE CONTAINING THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF A PRE-FILLED SYRINGE WITH THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF ONE SUITABLE DEVICE FOR SUBCUTANEOUS APPLICATION, SUCH AS AN INJECTOR IN THE BODY AND USE OF HISTIDINE TO INCREASE THE CIO-INH BIOAVAILABILITY ADMINISTERED SUBCUTANEOUSLY

PREPARATION OF C1-ESTERASE INHIBITOR (C1-INH), KIT THAT CONSISTS OF A FIRST RECEPTACLE CONTAINING THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF A PRE-FILLED SYRINGE WITH THE PREPARATION OF C1-INH, KIT THAT CONSISTS OF ONE SUITABLE DEVICE FOR SUBCUTANEOUS APPLICATION, SUCH AS AN INJECTOR IN THE BODY AND USE OF HISTIDINE TO INCREASE THE CIO-INH BIOAVAILABILITY ADMINISTERED SUBCUTANEOUSLY

机译:包含C1-INH的C1酯酶抑制剂(C1-INH)的制备试剂盒,其中包含预填充注射器的C1-INH的试剂盒包含制备的C1-INH的KIT用于皮下注射的设备,例如作为体内注射剂和使用组氨酸来增加皮下注射引起的CIO-INH生物利用度

摘要

the present invention relates to a stable c1-esterase (c1-inh) inhibitor preparation, which is liquid or lyophilized, characterized by a histidine content of 5 to 400 mm, but does not contain citrate or phosphate. the present invention further relates to a kit that includes the preparation of c1-inh.
机译:本发明涉及稳定的c1-酯酶(c1-inh)抑制剂制剂,其是液体或冻干的,其特征在于组氨酸含量为5-400mm,但不含柠檬酸盐或磷酸盐。本发明进一步涉及包含c1-inh制剂的试剂盒。

著录项

  • 公开/公告号BR112019023737A2

    专利类型

  • 公开/公告日2020-05-26

    原文格式PDF

  • 申请/专利权人 OCTAPHARMA AG;

    申请/专利号BR20191123737

  • 申请日2018-05-16

  • 分类号A61K38/57;

  • 国家 BR

  • 入库时间 2022-08-21 11:18:26

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号